Cancer Prevention and Early Detection in Patients With Cardiovascular Disease DOI Creative Commons
Pietro Ameri, Susan Dent

JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 962 - 964

Published: Dec. 1, 2024

Language: Английский

Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD DOI
Kathryn E. Weaver, Emily V. Dressler, Heidi D. Klepin

et al.

Journal of Clinical Oncology, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 21, 2024

PURPOSE Guidelines recommend cardiovascular (CV) risk assessment and counseling for cancer survivors. This study evaluated the automated heart-health (AH-HA) clinical decision support tool to promote provider-patient CV health (CVH) discussions in outpatient oncology. METHODS The AH-HA trial (WF-1804CD), coordinated by Wake Forest National Cancer Institute Community Oncology Research Program Base, randomized practices or usual care (UC) enrolled survivors receiving routine ≥6 months after curative treatment. displayed American Heart Association Life's Simple 7 CVH factors (BMI, physical activity, diet, smoking status, blood pressure, cholesterol, glucose), populated from electronic record (EHR), alongside treatments received with cardiotoxic potential. primary end point was survivor-reported discussion of nonideal missing factors. A mixed-effects logistic regression model assessed effect on discussions, adjusting practice. RESULTS Five UC four 645 (82% breast, 8% endometrial, 5% colorectal, lymphoma, prostate, multiple types) October 1, 2020, February 28, 2023. Most were female (96%; 84% White/non-Hispanic, Black; 3% Hispanic). Nearly all (98%) reported a ≥1 factor compared 55% ( P < .001). average number discussed higher (mean, 4.06 v 1.27; .001), as EHR-documented (3.83 0.77; = .03). Survivors also significantly more likely report recommendation see provider (39%) (25%, .02). Reported recommendations cardiologist low (approximately 6%) did not differ between groups. CONCLUSION effective at promoting during follow-up consult care.

Language: Английский

Citations

5

Changes in Physical Activity and Cardiovascular Disease Risk in Cancer Survivors DOI Creative Commons
Wonyoung Jung, In Young Cho,

Jinhyung Jung

et al.

JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 879 - 889

Published: Dec. 1, 2024

Cancer survivors face an elevated risk of cardiovascular disease, with physical inactivity after cancer treatment potentially worsening this risk. The aim study was to investigate the association between activity before and a diagnosis for heart disease. A nationwide cohort 269,943 (mean age 56.3, 45.7% men) evaluated adherence 2 years diagnosis. primary outcomes were incidence myocardial infarction (MI), failure (HF), atrial fibrillation. Subdistribution HRs (sHRs) 95% CIs calculated using Gray's method, accounting death as competing Over follow-up period 1,111,329.28 person-years, compared those who remained inactive, persistent associated 20% reduction in MI (sHR: 0.80; CI: 0.70-0.91) 16% HF 0.84; 0.78-0.90). Initiating linked 11% lower 0.89; 0.79-0.99) 13% 0.87; 0.82-0.93). Being active only 0.71-0.91) 6% 0.94; 0.88-1.00). No observed fibrillation Associations varied by site. These findings underscore importance maintaining health suggest that may offer enduring protection against ischemic disease cardiac dysfunction.

Language: Английский

Citations

5

Frailty DOI Creative Commons
Mina S. Sedrak, Aarti Asnani

JACC CardioOncology, Journal Year: 2025, Volume and Issue: 7(2), P. 122 - 124

Published: Feb. 1, 2025

Citations

0

Racial and Ethnic Disparities in Cardio-Oncology Care DOI
Olayiwola Akeem Bolaji,

Michelle N. Johnson

Current Cardiology Reports, Journal Year: 2025, Volume and Issue: 27(1)

Published: April 8, 2025

Language: Английский

Citations

0

Bridging Cancer and Cardiovascular Health: A Comprehensive Review of Cardiotoxicity in Modern Oncology DOI Creative Commons

Anjali Rajpoot,

Veena Sharma

Heart and Mind, Journal Year: 2025, Volume and Issue: 9(2), P. 115 - 135

Published: March 1, 2025

Abstract As survival rates for cancer patients improve due to advancements in treatment modalities, there is an increasing prevalence of cardiovascular complications, necessitating a comprehensive understanding this intersection. This review aims elucidate the intricate relationship between and disease, highlighting growing concern toxicity associated with therapies. It explores various treatments, including chemotherapy, targeted therapies, radiation, their risks, such as heart failure ischemic disease. In addition, it discusses importance proactive risk assessments ongoing monitoring mitigate adverse outcomes. Strategies prevention management, lifestyle modifications pharmacologic interventions, are also examined support health survivors. Unlike previous reviews, work integrates insights from multidisciplinary collaborations, emphasizing underexplored mechanisms role innovative tools. highlights emerging therapeutic strategies tailored these providing forward-looking perspective critical area research. The need collaborative method that includes oncologists, cardiologists, primary care providers emphasized ensure integrated addresses both health. serves resource healthcare professionals seeking long-term outcomes survivors by recognizing managing risks.

Language: Английский

Citations

0

Understanding and Reducing the Social and Environmental Determinants of Health Disparities in Cardio-Oncology DOI Creative Commons
Bonnie Ky

JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(3), P. 473 - 474

Published: June 1, 2024

Language: Английский

Citations

0

Cancer Prevention and Early Detection in Patients With Cardiovascular Disease DOI Creative Commons
Pietro Ameri, Susan Dent

JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 962 - 964

Published: Dec. 1, 2024

Language: Английский

Citations

0